Acer Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Acer Therapeutics

16/05/2023 01:10

* Acer Therapeutics Inc  ACER.OQ  reported a quarterly
adjusted
loss of 77 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 28 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Acer Therapeutics Inc's reported EPS for the quarter was a
loss
of 77 cents​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Acer Therapeutics Inc shares had risen by 0.5% this
quarter and
lost 69.6% so far this year.
    * The company reported a quarterly loss of $16.28 million.
    * Wall Street's median 12-month price target for Acer
Therapeutics
Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
16 at 12:10 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.28          -0.77          Missed
 Dec. 31 2022      -0.37          -0.54          Missed
 Sep. 30 2022      -0.68          -0.31          Beat
 Jun. 30 2022      -0.57          -0.17          Beat